Article révisé par les pairs
Titre:
  • A Four-Gene Promoter Methylation Marker Panel Consisting of GREM1, NEURL, LAD1, and NEFH Predicts Survival of Clear Cell Renal Cell Cancer Patients.
Auteur:Van Vlodrop, Iris J H; Joosten, Sophie C; De Meyer, Tim; Smits, Kim M; Van Neste, Leander; Melotte, Veerle; Baldewijns, Marcella M L L M.M.L.L.; Schouten, Leo J; van den Brandt, Piet A; Jeschke, Jana; Yi, Joo Mi; Schuebel, Kornel K.E.; Ahuja, Nita; Herman, James G; Aarts, Maureen Jb; Bosman, Fred T; Van Criekinge, Wim; van Engeland, Manon
Informations sur la publication:Clinical cancer research, 23, 8, page (2006-2018)
Statut de publication:Publié, 2017
Sujet CREF:Sciences bio-médicales et agricoles
MeSH keywords:Adult
Aged
Autoantigens -- genetics
Biomarkers, Tumor -- genetics
Carcinoma, Renal Cell -- genetics -- mortality
DNA Methylation -- genetics
Disease-Free Survival
Female
High-Throughput Nucleotide Sequencing
Humans
Intercellular Signaling Peptides and Proteins -- genetics
Kaplan-Meier Estimate
Kidney Neoplasms -- genetics -- mortality
Male
Middle Aged
Neurofilament Proteins -- genetics
Non-Fibrillar Collagens -- genetics
Oligonucleotide Array Sequence Analysis
Prognosis
Promoter Regions, Genetic -- genetics
Proportional Hazards Models
Ubiquitin-Protein Ligases -- genetics
Langue:Anglais
Identificateurs:urn:issn:1078-0432
info:doi/10.1158/1078-0432.CCR-16-1236
info:pii/1078-0432.CCR-16-1236
info:scp/85018797676
info:pmid/27756787

Documents en relation

DI-fusion